Skip to main content
Erschienen in: Supportive Care in Cancer 4/2011

01.04.2011 | Original Article

Effect of virtual reality on time perception in patients receiving chemotherapy

verfasst von: Susan M. Schneider, Cassandra K. Kisby, Elizabeth P. Flint

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Virtual reality (VR) during chemotherapy has resulted in an elapsed time compression effect, validating the attention diversion capabilities of VR. Using the framework of the pacemaker–accumulator cognitive model of time perception, this study explored the influence of age, gender, state anxiety, fatigue, and cancer diagnosis in predicting the difference between actual time elapsed during receipt of intravenous chemotherapy while immersed in a VR environment versus patient’s retrospective estimates of time elapsed during this treatment.

Materials and methods

This secondary analysis from three studies yielded a pooled sample of N = 137 participants with breast, lung, or colon cancer. Each study employed a crossover design requiring two matched intravenous chemotherapy treatments, with participants randomly assigned to receive VR during one treatment. Regressions modeled the effect of demographic variables, diagnosis, and Piper Fatigue Scale and State Anxiety Inventory scores on the difference between actual and estimated time elapsed during chemotherapy with VR.

Results

In a forward regression model, three predictors (diagnosis, gender, and anxiety) explained a significant portion of the variability for altered time perception (F=5.06, p = 0.0008). Diagnosis was the strongest predictor; individuals with breast and colon cancer perceived time passed more quickly.

Conclusions

VR is a noninvasive intervention that can make chemotherapy treatments more tolerable. Women with breast cancer are more likely and lung cancer patients less likely to experience altered time perception during VR (a possible indicator of effectiveness for this distraction intervention). Understanding factors that predict responses to interventions can help clinicians tailor coping strategies to meet each patient’s needs.
Fußnoten
1
Sony PC Glasstron PLM-S700 or iO Display Systems Inc. i-Glasses SVGA 3D.
 
Literatur
1.
7.
Zurück zum Zitat Chernecky C (1999) Temporal differences in coping, mood, and stress with chemotherapy. Cancer Nurs 22(4):266–276PubMedCrossRef Chernecky C (1999) Temporal differences in coping, mood, and stress with chemotherapy. Cancer Nurs 22(4):266–276PubMedCrossRef
8.
Zurück zum Zitat Cohen L, de Moor CA, Eisenberg P, Ming EE, Hu H (2007) Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings. Support Care Cancer 15(5):497–503. doi:10.1007/s00520-006-0173-z PubMedCrossRef Cohen L, de Moor CA, Eisenberg P, Ming EE, Hu H (2007) Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings. Support Care Cancer 15(5):497–503. doi:10.​1007/​s00520-006-0173-z PubMedCrossRef
10.
Zurück zum Zitat Dahlquist LM, Weiss KE, Clendaniel LD, Law EF, Ackerman CS, McKenna KD (2009) Effects of videogame distraction using a virtual reality type head-mounted display helmet on cold pressor pain in children. J Pediatr Psychol 34(5):574–584. doi:10.1093/jpepsy/jsn023 PubMedCrossRef Dahlquist LM, Weiss KE, Clendaniel LD, Law EF, Ackerman CS, McKenna KD (2009) Effects of videogame distraction using a virtual reality type head-mounted display helmet on cold pressor pain in children. J Pediatr Psychol 34(5):574–584. doi:10.​1093/​jpepsy/​jsn023 PubMedCrossRef
13.
18.
Zurück zum Zitat Hoffman HG, Richards TL, Bills AR, Van Oostrom T, Magula J, Seibel EJ, Sharar SR (2006) Using FMRI to study the neural correlates of virtual reality analgesia. CNS Spectr 11(1):45–51PubMed Hoffman HG, Richards TL, Bills AR, Van Oostrom T, Magula J, Seibel EJ, Sharar SR (2006) Using FMRI to study the neural correlates of virtual reality analgesia. CNS Spectr 11(1):45–51PubMed
19.
Zurück zum Zitat Hofman M, Morrow GR, Roscoe JA, Hickok JT, Mustian KM, Moore DF, Wade JL, Fitch TR (2004) Cancer patients’ expectations of experiencing treatment-related side effects: a University of Rochester Cancer Center-community clinical oncology program study of 938 patients from community practices. Cancer 101(4):851–857. doi:10.1002/cncr.20423 PubMedCrossRef Hofman M, Morrow GR, Roscoe JA, Hickok JT, Mustian KM, Moore DF, Wade JL, Fitch TR (2004) Cancer patients’ expectations of experiencing treatment-related side effects: a University of Rochester Cancer Center-community clinical oncology program study of 938 patients from community practices. Cancer 101(4):851–857. doi:10.​1002/​cncr.​20423 PubMedCrossRef
20.
22.
Zurück zum Zitat Magora F, Cohen S, Shochina M, Dayan E (2006) Virtual reality immersion method of distraction to control experimental ischemic pain. Isr Med Assoc J 8(4):261–265PubMed Magora F, Cohen S, Shochina M, Dayan E (2006) Virtual reality immersion method of distraction to control experimental ischemic pain. Isr Med Assoc J 8(4):261–265PubMed
26.
Zurück zum Zitat Molassiotis A, Saunders MP, Valle J, Wilson G, Lorigan P, Wardley A, Levine E, Cowan R, Loncaster J, Rittenberg C (2008) A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre. Support Care Cancer 16(2):201–208. doi:10.1007/s00520-007-0343-7 PubMedCrossRef Molassiotis A, Saunders MP, Valle J, Wilson G, Lorigan P, Wardley A, Levine E, Cowan R, Loncaster J, Rittenberg C (2008) A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre. Support Care Cancer 16(2):201–208. doi:10.​1007/​s00520-007-0343-7 PubMedCrossRef
28.
Zurück zum Zitat Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised piper fatigue scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25(4):677–684PubMed Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised piper fatigue scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25(4):677–684PubMed
29.
Zurück zum Zitat Roscoe JA, Morrow GR, Colagiuri B, Heckler CE, Pudlo BD, Colman L, Hoelzer K, Jacobs A (2010) Insight in the prediction of chemotherapy-induced nausea. Support Care Cancer. doi:10.1007/s00520-009-0723-2 Roscoe JA, Morrow GR, Colagiuri B, Heckler CE, Pudlo BD, Colman L, Hoelzer K, Jacobs A (2010) Insight in the prediction of chemotherapy-induced nausea. Support Care Cancer. doi:10.​1007/​s00520-009-0723-2
33.
34.
Zurück zum Zitat Schneider SM, Workman ML (2000) Virtual reality as a distraction intervention for older children receiving chemotherapy. Pediatr Nurs 26(6):593–597PubMed Schneider SM, Workman ML (2000) Virtual reality as a distraction intervention for older children receiving chemotherapy. Pediatr Nurs 26(6):593–597PubMed
36.
Zurück zum Zitat Somov PG (2000) Time perception as a measure of pain intensity and pain type. J Back Musculoskelet Rehabil 14(3):111–121 Somov PG (2000) Time perception as a measure of pain intensity and pain type. J Back Musculoskelet Rehabil 14(3):111–121
37.
Zurück zum Zitat Spielberger CD (1983) Manual for the State-Trait Anxiety Inventory. Consulting Psychologist Press, Palo Alto Spielberger CD (1983) Manual for the State-Trait Anxiety Inventory. Consulting Psychologist Press, Palo Alto
38.
Zurück zum Zitat Thuné-Boyle ICV, Myers LB, Newman SP (2006) The role of illness beliefs, treatment beliefs, and perceived severity of symptoms in explaining distress in cancer patients during chemotherapy treatment. Behav Med 32(1):19–29. doi:10.3200/BMED.32.1.19-29 PubMedCrossRef Thuné-Boyle ICV, Myers LB, Newman SP (2006) The role of illness beliefs, treatment beliefs, and perceived severity of symptoms in explaining distress in cancer patients during chemotherapy treatment. Behav Med 32(1):19–29. doi:10.​3200/​BMED.​32.​1.​19-29 PubMedCrossRef
40.
Zurück zum Zitat Verdura GS, Alaimo S, Borzì R, Fazio M, Scavo V (2005) Trying to listen: needs of patients treated with chemotherapy. Support Palliat Cancer Care 2(1):15–20 Verdura GS, Alaimo S, Borzì R, Fazio M, Scavo V (2005) Trying to listen: needs of patients treated with chemotherapy. Support Palliat Cancer Care 2(1):15–20
44.
Zurück zum Zitat Wittmann M, Vollmer T, Schweiger C, Hiddemann W (2006) The relation between the experience of time and psychological distress in patients with hematological malignancies. Palliat Support Care 4(4):357–363. doi:10.1017/S1478951506060469 PubMedCrossRef Wittmann M, Vollmer T, Schweiger C, Hiddemann W (2006) The relation between the experience of time and psychological distress in patients with hematological malignancies. Palliat Support Care 4(4):357–363. doi:10.​1017/​S147895150606046​9 PubMedCrossRef
45.
Zurück zum Zitat Yoo HJ, Ahn SH, Kim SB, Kim WK, Han OS (2005) Efficacy of progressive muscle relaxation training and guided imagery in reducing chemotherapy side effects in patients with breast cancer and in improving their quality of life. Support Care Cancer 13(10):826–833. doi:10.1007/s00520-005-0806-7 PubMedCrossRef Yoo HJ, Ahn SH, Kim SB, Kim WK, Han OS (2005) Efficacy of progressive muscle relaxation training and guided imagery in reducing chemotherapy side effects in patients with breast cancer and in improving their quality of life. Support Care Cancer 13(10):826–833. doi:10.​1007/​s00520-005-0806-7 PubMedCrossRef
46.
Zurück zum Zitat Zachariae R, Paulsen K, Mehlsen M, Jensen AB, Johansson A, von der Maase H (2007) Anticipatory nausea: the role of individual differences related to sensory perception and autonomic reactivity. Ann Behav Med 33(1):69–79. doi:10.1207/s15324796abm3301_8 PubMedCrossRef Zachariae R, Paulsen K, Mehlsen M, Jensen AB, Johansson A, von der Maase H (2007) Anticipatory nausea: the role of individual differences related to sensory perception and autonomic reactivity. Ann Behav Med 33(1):69–79. doi:10.​1207/​s15324796abm3301​_​8 PubMedCrossRef
Metadaten
Titel
Effect of virtual reality on time perception in patients receiving chemotherapy
verfasst von
Susan M. Schneider
Cassandra K. Kisby
Elizabeth P. Flint
Publikationsdatum
01.04.2011
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2011
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-010-0852-7

Weitere Artikel der Ausgabe 4/2011

Supportive Care in Cancer 4/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.